dipyridamole has been researched along with hydrazine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bech, FR; Cronenwett, JL; Freeman, DH; McDaniel, MD; Ogletree, ML | 1 |
Pandey, P; Rane, N; Sharma, P | 1 |
Blair, P; Chakrabarti, S; Freedman, JE; Wu, C | 1 |
5 other study(ies) available for dipyridamole and hydrazine
Article | Year |
---|---|
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
The effect of thromboxane receptor blockade versus thromboxane synthase inhibition on canine arterial graft patency.
Topics: Animals; Aspirin; Benzofurans; Bridged Bicyclo Compounds, Heterocyclic; Dipyridamole; Dogs; Fatty Acids, Unsaturated; Graft Occlusion, Vascular; Hydrazines; Male; Platelet Aggregation; Receptors, Prostaglandin; Receptors, Thromboxane; Thromboxane A2; Thromboxane-A Synthase; Vascular Patency | 1990 |
Synthesis and evaluation of antimicrobial activity of novel hydrazino and N-benzylidinehydrazino-substituted 4,8-dihydro-1H,3H-pyrimido[4,5-d]pyrimidin-2,7-dithiones.
Topics: Anti-Infective Agents; Dipyridamole; Escherichia coli; Gram-Positive Bacteria; Hydrazines; Microbial Sensitivity Tests; Models, Chemical; Models, Molecular; Molecular Structure; Pseudomonas aeruginosa; Structure-Activity Relationship | 2006 |
Redox state of dipyridamole is a critical determinant for its beneficial antioxidant and antiinflammatory effects.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biphenyl Compounds; Blood Platelets; CD40 Ligand; Cell Adhesion Molecules; Dipyridamole; Endothelial Cells; Ferric Compounds; HL-60 Cells; Humans; Hydrazines; Hydrogen Peroxide; I-kappa B Proteins; Lipoproteins, LDL; Mice; Mice, Inbred C57BL; Microfilament Proteins; NF-kappa B; NF-KappaB Inhibitor alpha; Oxidation-Reduction; Phosphoproteins; Phosphorylation; Picrates; Platelet Adhesiveness; Reactive Oxygen Species; Spectrometry, Fluorescence; Transcription Factor RelA; Tumor Necrosis Factor-alpha | 2007 |